OpenLobby.EU
Explore

Cancer Research UK

CRUK

Cancer Research UK is the world’s leading cancer charity, dedicated to saving and improving lives through our research, influence and information.

Lobbying Activity

Meeting with Joanna Drake (Deputy Director-General Research and Innovation)

26 Feb 2025 · Exchange on main ongoing initiatives and priorities for the EU Cancer Mission and Cancer Research UK, aiming at highlighting areas of common interest to strengthen cooperation.

Meeting with Stella Kyriakides (Commissioner) and

14 Mar 2024 · Meeting with Cancer Research UK

Response to A European Health Data Space

27 Jul 2022

Research is global and therefore access to data, with appropriate safeguards, should be global. Cancer Research UK (CRUK) is the world's largest charitable funder of cancer research. We draw on the strength of our network and collaborate with partners around the world to save and improve many more lives than we could alone, bringing hope to people affected by cancer everywhere. CRUK has a new Research Data Strategy with privacy and patient involvement at the centre. In line with this strategy, we are piloting our own Trusted Research Environment for researchers/organisations across the four UK nations. (For more information see https://www.cancerresearchuk.org/TRE). As cancer incidence continues to increase around the world, research into preventing the disease is becoming ever more critical as a route to saving lives. We partner with international research organisations - including many in the EU - to support collaboration and help drive a shared cancer research agenda. Our researchers work closely with EU partners to share expertise, pool data and work at a scale they could not do on their own. The UK is a world-leader in the development and running of clinical trials, and our thriving research environment is underpinned by international collaboration. 32% of CRUK-funded trials involve patients from at least one other EU country. Over 4,800 UK-EU trials took place between 2004 and 2016 (ref: https://www.cancerresearchuk.org/about-us/we-develop-policy/we-work-with-government/exiting-the-eu/uk-and-eu-research). Working collaboratively across borders is particularly vital for rare and childhood cancers, where one country alone may not have enough participants to run a trial. We recognise that we are at a moment of huge opportunity in terms of our ability to understand cancer and find ways to beat it. New ways of thinking about cancer, new technologies and growing global networks have transformed what’s possible. The pandemic has shown the value of investing in research, how global collaboration can radically accelerate progress and how quickly innovations can be adopted by health systems when there’s real focus. But we also know that making discoveries alone is not enough. We want many more discoveries to be turned into tests, treatments and prevention measures that can save and improve lives around the world. Sharing health data for research, with appropriate safeguards, is vital to the mission we all share. More about CRUK here: https://www.cancerresearchuk.org/about-us/our-organisation/our-strategy-to-beat-cancer See also: The impact of collaboration: The value of UK medical research to EU science and health (2017) https://www.cancerresearchuk.org/about-us/we-develop-policy/we-work-with-government/exiting-the-eu/uk-and-eu-research The UK and EU: What people affected by cancer need from the new relationship (2020) https://www.cancerresearchuk.org/sites/default/files/whatpatientsneedfinal.pdf
Read full response

Meeting with Maria Koleva (Cabinet of Commissioner Mariya Gabriel)

3 Mar 2020 · Horizon Europe - Mission on Cancer

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

7 Mar 2018 · Impact of Brexit on cancer research

Response to Good Clinical Practice Inspections Procedures

26 Oct 2016

Cancer Research UK is the world’s largest independent cancer charity dedicated to saving lives through research. It supports research into all aspects of cancer and this is achieved through the work of over 4,000 scientists, doctors and nurses. In 2015/16, we spent £432 million on research in institutes, hospitals and universities across the UK. We receive no funding from the Government for our research and are dependent on fundraising with the public. Cancer Research UK wants to accelerate progress so that three in four people survive their cancer for 10 years or more by 2034. Of the trials that Cancer Research UK directly funds – currently over 200 - more than a quarter involve at least one other EU country. Cancer Research UK is highly supportive of collaborative research and understands the vital importance of having a regulatory framework that supports global collaboration. Pan-EU trials are especially important for rarer cancers and childhood cancers, where trials are often only feasible because they are able to recruit from a large pool of patients. Working in partnership with sector colleagues across Europe, the UK research community has played a key role in helping shape EU regulations for the benefit of patients across Europe and we have valued the opportunity to review, and share our support, for this Implementing Regulation.
Read full response